C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
167/245, 167/275
C07C 217/64 (2006.01) A61K 31/135 (2006.01) C07D 317/58 (2006.01)
Patent
CA 1329937
ABSTRACT OF THE DISCLOSURE The present invention provides compounds of the general formula (I): Image (I) wherein: each of R1 and R2 independently is hydrogen or methyl; R3 is hydrogen, halo, C1-C4 alkyl, C1-C3 alkoxy or trifluoromethyl; each R4 independently is hydrogen, halo, C1-C4 alkyl, C1-C3 alkoxy or trifluoromethyl; m is 1 or 2; when m is 2, each R4 can be combined to form methylenedioxy; and pharmaceutically acceptable acid addition salts thereof. Also provided are pharmaceutical compositions comprising a compound of formula (I) as described above, as the active ingredient. These compounds are selective inhibitors of serotonin uptake, and are useful for the treatment of such conditions as obesity, depression, alcoholism,loss of memory, and anxiety.
563374
Robertson David Wayne
Thompson Dennis Charles
Wong David Taiwai
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
1-phenyl-3-naphthalenyloxypropanamines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-phenyl-3-naphthalenyloxypropanamines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-phenyl-3-naphthalenyloxypropanamines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1324990